The HRS9531-201 clinical trial was a multi-centre, randomised, double-blind, placebo-parallel controlled Phase 2 clinical study (NCT05881837) conducted by Hengrui Pharma in China to evaluate the efficacy and safety of HRS9531 injection in adults (aged 18-65) with obesity (BMI of 2840 kg/m2) without type 2 diabetes
Tan, S., Sukumar, N., Abramovitch, R
Lightweight and non-greasy sunscreens are ideal for daily use
As a novel inhibitor of nicotinamide N-methyltransferase (NNMT), 5-amino-1mq has shown broad application prospects in anti-aging studies
Un mdico colegiado en la UE puede revisar tu caso a travs de la consulta online de Hi-Doctor
das Produkt hat einen leichten Eigengeschmack, sobald in Wasser oder einem Getrnk aufgelst ist es neutral